This inventor holds 1 USPTO granted patent. Top assignee: Association Pour Le Développement De La Biothérapie Expérimentale Et Appliquée. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Francoise Chany-Fournier: Innovator in Biotherapy
Introduction
Francoise Chany-Fournier is a notable inventor based in Paris, France. He has made significant contributions to the field of biotherapy, particularly through his innovative research and patents. His work focuses on the development of compounds with lectinic properties and their applications in therapeutics.
Latest Patents
Chany-Fournier holds a patent for "Compounds having lectinic properties and their biological applications." This invention relates to nucleotide sequences capable of coding for polypeptides with lectinic properties, specifically those of the sarcolectin type. The patent outlines the use of these polypeptides to stimulate immunity, potentially in combination with interferon or butyroids. Additionally, it discusses the use of specific inhibitors or antagonist peptides to counteract the production of SCL. Antibodies directed against these peptides can be utilized in diagnostics and therapeutics.
Career Highlights
Chany-Fournier is associated with the Association Pour Le Développement De La Biothérapie Expérimentale Et Appliquée, where he continues to advance his research in biotherapy. His work has garnered attention for its potential impact on therapeutic applications and immune system stimulation.
Collaborations
Chany-Fournier has collaborated with notable colleagues, including Pan Hong Jiang and Italina Cerutti, who contribute to his research endeavors. Their combined expertise enhances the development of innovative therapeutic solutions.
Conclusion
Francoise Chany-Fournier is a pioneering inventor whose work in biotherapy has the potential to revolutionize therapeutic practices. His patent on lectinic compounds showcases his commitment to advancing medical science and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile